Pharmafile Logo
Pharmafocus logo
Advanced Search

brexit

Showing 15 posts of 137 posts found.

img_4190-e1376666350337-web

New targeted lung cancer treatment coming to UK under MHRA scheme

July 15, 2021
MHRA, NSCLC, UK, brexit

The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …

News
img_4190-e1376666350337-web

Sickle cell therapy granted innovation passport by MHRA

June 30, 2021
Research and Development MHRA, SCD, brexit

Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …

News

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

Feature
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!

News
brexit-hintergrund_web

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

October 19, 2020
Sales and Marketing ABPI, EU, UK, brexit, pharma

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a no-deal scenario with the European …

News
uk_gobtg

UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns

August 4, 2020
Manufacturing and Production UK, brexit, coronavirus

The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …

News
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …

News
ususnsu

Majority of British people worried about the fate of the NHS in post-Brexit US trade deal, survey reveals

November 28, 2019
Medical Communications Boris Johnson, Jeremy Corbyn, NHS, Trump, brexit, european union

In a newly released survey on “Over-The-Counter (OTC) and Pharma 2019”, by the business data platform Statista, 55% of people …

News
222170359

Damage control: How will pharma manage the health economic impacts of Brexit?

October 23, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, brexit, health economics and outcomes research, pharma

When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …

Feature
brexit-hintergrund_web

“No deal” Brexit and life sciences: What happens?

October 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Europe, UK, brexit, no deal, no-deal, pharma

Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …

Feature
pharmafocus_sept_2019_cover

Read the September edition of Pharmafocus online now!

September 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mylan, brexit

It’s Friday, meaning the weekend is within reach and it’s time for a rundown of the most popular articles on …

News
470px-blank_ireland

Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority

September 5, 2019
Medical Communications, Sales and Marketing England, Ireland, UK, brexit, pharma

Though MPs are moving forward with their plan to block UK Prime Minister Boris Johnson’s supposed no-deal Brexit from the …

News
brexit_flag

No-deal Brexit will “make the disintegration of the health service an ever more real prospect”, BMA warns

September 2, 2019
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, NHS, UK, brexit, pharma

As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has …

News
brexit_predictions

British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal

August 19, 2019
Sales and Marketing EU, UK, US, brexit, brexit delay, healthcare, no-deal, pharma

The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that …

News

Latest content

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024